Underlying dyslipidemia postpartum in women with a recent gdm pregnancy who develop type 2 diabetes

25Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Approximately, 35% of women with Gestational Diabetes (GDM) progress to Type 2 Diabetes (T2D) within 10 years. However, links between GDM and T2D are not well understood. We used a well-characterised GDM prospective cohort of 1035 women following up to 8 years postpartum. Lipidomics profiling covering >1000 lipids was performed on fasting plasma samples from participants 6–9 week postpartum (171 incident T2D vs. 179 controls). We discovered 311 lipids positively and 70 lipids negatively associated with T2D risk. The upregulation of glycerolipid metabolism involving triacylglycerol and diacylglycerol biosynthesis suggested activated lipid storage before diabetes onset. In contrast, decreased sphingomyelines, hexosylceramide and lactosylceramide indicated impaired sphingolipid metabolism. Additionally, a lipid signature was identified to effectively predict future diabetes risk. These findings demonstrate an underlying dyslipidemia during the early postpartum in those GDM women who progress to T2D and suggest endogenous lipogenesis may be a driving force for future diabetes onset.

Cite

CITATION STYLE

APA

Lai, M., Rijjal, D. A., Röst, H. L., Dai, F. F., Gunderson, E. P., & Wheeler, M. B. (2020). Underlying dyslipidemia postpartum in women with a recent gdm pregnancy who develop type 2 diabetes. ELife, 9, 1–17. https://doi.org/10.7554/ELIFE.59153

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free